Vimizim (elosulfase alfa)

pCPA File Number: 20945
Negotiation Status:
Concluded with an LOI
Indication(s):
Mucopolysaccharidosis IVA (Morquio A syndrome)
Sponsor/Manufacturer:
BioMarin Pharmaceutical Inc.
CADTH Project Number:
SR0456-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: